idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
E m b a r g o ed until: Thursday, December 7, 2006, 16.15 pm, 15.15 GMT
Gliomas are extremely malignant and fast growing tumors. Not only do they secrete molecules to secure their blood supply by generating new blood vessels, they are also able to secrete messenger molecules to protect themselves against attacks by the immune system. Professor Michael Weller, Medical Director of the General Neurology at the University Clinic in Tübingen, applied the RNA-interference technique to block the gene of one important representative of this group of messengers, the Transforming Growth Factor-beta (TGF-beta). When the TGF-beta gene is switched off and the blockage of the immune system lifted, brain tumors can be attacked by the immune system. In all of the mice in which the researchers had switched off the TGF-beta gene, the tumors were completely decomposed. "These results could open the way for vaccinations against brain tumors, because only an immune system which is working faultlessly is able to react to a vaccination with an adequate immune response, Professor Weller said at the Brain Tumor Conference 2006 held by the Max Delbrück Center for Molecular Medicine (MDC) and the Helios Klinikum in Berlin-Buch, Germany.
Tumors in the brain are attacked less often by the immune system than tumors in other parts of the body. The reason for this is, amongst others, that the blood-brain barrier protects the brain from the pathogens transported in the blood vessels. However, this also means that the brain is simultaneously less accessible to the immune system than are other parts of the body. Therefore, researchers thought for a long time that the immune system was not active in the brain at all.
Yet, in recent years, researchers were able to demonstrate immune reactions in the brain. Multiple sclerosis, for example, is caused by an extreme immune reaction likewise in the brain. Furthermore, researchers could show that the brain tumor cells indeed defend themselves against attacks by the immune system. These cells produce messenger molecules that block the immune system of the patient. A multitude of such molecules had already been identified by scientists. For example, substances with complicated names such as Transforming Growth Factor-beta (TGF-beta), Regeneration and Tolerance Factor (RTF), and the soluble surface antigen HLA-G.
Since 1994, Professor Weller has been working on a mechanism to switch off the messenger TGF-beta directly so that the immune system will be able to recognize and attack tumor cells. In experiments with mice and rats, he blocked the gene for TGF-beta with the help of the so called RNA interference (RNAi) method. RNA stands for "ribonucleic acid", a molecule which translates the genetic code found in the DNA into the language of proteins (amino acids). The RNAi is a strand of antisense RNA that binds and blocks the RNA strand of the TGF-beta gene switched on in the tumor. Thus, the RNAi prevents the translation of the TGF-beta gene into its corresponding protein. In other words, the gene is quasi silenced and no TGF-beta protein is produced.
Furthermore, Professor Weller could show that certain cells of the immune system, like lymphocytes and natural killer cells, are able to recognize and destroy the tumor. To prevent a recurrence of the tumor, the researchers additionally vaccinated the mice with dead tumor cells. "These dead cells cannot proliferate anymore. Therefore, they are not dangerous for the organism", Professor Weller pointed out. But their cell surface characteristics are the same as "regular" tumor cells and, therefore, they can stimulate the immune system. Only when the immune system is no longer blocked by TGF-beta can an effective immune response be provoked by these vaccinations. "At this time, such strategies are merely experimental as we did all our research on animals. These methods cannot yet be transferred to human patients", Professor Weller emphasized.
Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de
http://www.mdc-berlin.de/englisch/about_the_mdc/public_relations/e_index.h
Merkmale dieser Pressemitteilung:
Biologie, Chemie, Ernährung / Gesundheit / Pflege, Informationstechnik, Medizin
überregional
Buntes aus der Wissenschaft, Forschungsergebnisse, Wissenschaftliche Tagungen
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
